Background-The differences in the incidence of heart failure by race/ethnicity and the potential mechanisms for these differences are largely unexplored in women. Methods and Results-A total of 156 143 postmenopausal women free of self-reported heart failure enrolled from 1993 to 1998 at 40 clinical centers throughout the United States as part of the Women's Health Initiative and were followed up until 2005, for an average of 7.8 years, for incident hospitalized heart failure. Incident rates, hazard ratios (HRs), and 95% confidence intervals were determined by use of the Cox proportional hazard model comparing racial/ethnic groups, and population-attributable risk percentages were calculated for each racial/ethnic group. Blacks had the highest age-adjusted incidence of heart failure (380 in 100 000 person-years), followed by whites (274), Hispanics (193), and Asian/Pacific Islanders (103). The excess risk in blacks compared with whites (age-adjusted HRϭ1.45) was significantly attenuated by adjustment for household income (HRϭ0.97) and diabetes mellitus (HRϭ0.89), but the lower risk in Hispanics (age-adjusted HRϭ0.72) and Asian/Pacific Islanders (age-adjusted HRϭ0.44) remained despite adjustment for traditional risk factors, socioeconomic status, lifestyle, and access-to-care variables. The effect of adjustment for interim coronary heart disease on nonwhite versus white HRs for heart failure differed by race/ethnic group. Conclusions-Asian/Pacific Islander and Hispanic women have a lower incidence of heart failure and black women have higher rates of heart failure compared with white women. The excess risk of incident heart failure in black women is explained largely by adjustment for lower household incomes and diabetes mellitus in black women, whereas the lower rates of heart failure in Asian/Pacific Islanders and Hispanics are largely unexplained by the risk factors measured in this study. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000611. (Circulation. 2012;126:688-696.)
H eart failure (HF) is recognized by a constellation of signs and symptoms and a neurohumoral response to cardiac dysfunction. HF develops as a consequence of many forms of cardiovascular disease and is not a single pathological entity. Rates of HF are reaching epidemic proportions, affecting Ͼ5 million people in the United States with Ͼ500 000 newly diagnosed cases each year. 1 Both the prevalence and morbidity associated with HF are increasing in the United States, with racial and ethnic disparities noted. Despite advances in therapy and an improvement in the 5-year survival rate, the prognosis is still relatively poor. 2, 3 HF also imposes considerable economic impact on health services owing to the need for long-term, multipharmaceutical treatment, use of implantable defibrillators, and frequent hospitalizations. 4 Most previous work related to racial/ethnic differences in the prevalence of HF has suggested that differences may be attributable to the relative importance of different risk factors or access-to-care issues. 4 -11 However, such prevalence studies are prone to bias and lack temporality. A few recent studies have examined racial/ethnic differences in incident HF but had limited numbers of incident cases of HF and limited numbers of racial/ethnic groups for comparison. 12, 13 Also of interest are the sex differences in HF in both rates and risk factors because most studies of HF have included a limited number of women. Previous research suggests that women have more hypertension and valvular disease and less underlying coronary disease or dilated cardiomyopathy compared with men as potential risk factors for HF, but again, this research is limited to prevalence studies. 11, 14 Clinical Perspective on p 696
These limitations emphasize the need for larger prospective epidemiological studies clarifying the incidence and risk factors associated with HF in a multiracial cohort in postmenopausal women. We address the following research questions in a large, diverse nationwide cohort of postmenopausal women: Are there differences in the incidence of HF by race/ethnicity in postmenopausal women? If so, what sociodemographic, lifestyle, access-to-care, and traditional risk factors explain these differences? Which modifiable risk factors contribute to the burden of HF in different race/ethnic groups in postmenopausal women?
Methods

Study Population
The Women's Health Initiative (WHI) recruited women nationwide in 40 clinical centers between 1993 and 1998. [15] [16] [17] [18] Study participants were women 50 to 79 years of age at baseline. Women were excluded if they did not plan to reside in the area for at least 3 years, had medical conditions predictive of Ͻ3 years of survival, or had complicating conditions such as alcoholism, mental illness, or dementia. Those eligible for either the clinical trials or observational arm completed baseline assessments, including several selfadministered questionnaires of sociodemographic characteristics, medical history, reproductive and menstrual history, health behavior (including physical activity and diet), and family history of selected diseases. Trained staff obtained anthropometric measures, including height, weight, and waist circumference. After women sat quietly for 5 minutes, blood pressure was measured with a mercury manometer twice, 30 seconds apart, and the average was used in this analysis.
Medication use at baseline was ascertained by having the participants bring all the containers for medications taken for the 2 weeks before the baseline visit. Interviewers entered each medication into a central database, which assigned drug codes using Medi-Span software. Information was recorded on duration of use but not dose. White blood cell count and hemoglobin levels were measured via standardized automated technique on fresh samples at each local WHI site.
A standardized written protocol, centralized training of local clinical staff, local quality control, and periodic quality assurance visits by the Clinical Coordinating Center were used to maintain uniform data collection procedures at all study sites. Reproducibility of WHI questionnaire data was evaluated in a random subsample at 10 weeks with good to excellent reproducibility (weighted ϭ0.77-0.99). 15 
Covariates
Race was self-reported as American Indian or Alaskan Native, Asian or Pacific Islander, black or African American, Hispanic/Latino, white (not of Hispanic origin), or other.
For analytic purposes, age was categorized by age groups as Ͻ50 to 59, 60 to 69, or 70 to Ն79 years; education was categorized as less than high school or more than high school; income was categorized as less than $20 000, $20 000 to $35 000, $35 000 to $50 000, $50 000 to $75 000, and more than $75 000 per year; cigarette smoking was categorized as current, past, or never; hormone status was categorized as current, past, or never. Hyperlipidemia was defined as taking cholesterol-lowering medication. Hypertension was defined by self-report and taking antihypertensive medications, systolic blood pressure Ն140 mm Hg, or diastolic blood pressure Ն90 mm Hg. Uncontrolled systolic blood pressure was defined as systolic blood pressure Ͼ150 mm Hg and taking antihypertensive medications. Diabetes mellitus defined by self-report of physician diagnosis and taking hypoglycemic medications. Atrial fibrillation was based on self-report and not medication use.
Prevalent coronary heart disease (CHD) was defined as selfreporting at baseline as having been hospitalized for a heart attack (myocardial infarction), coronary angioplasty or stent, coronary artery bypass graft surgery, or angina (chest pains from heart problems).
Physical activity was ascertained from a series of questions related to walking and exercise at strenuous levels and physical activity at moderate-and low-intensity levels. A composite variable was constructed imputing the midpoint of the range of frequency and duration of walking, strenuous exercise, and moderate-and lowintensity physical activity to determine the hours of activity per week for each type of physical activity. A metabolic equivalent (MET) value was assigned to each level of activity, and a total physical activity score (MET-h/wk) was computed for each participant. 17 Alcohol intake was ascertained by asking participants to estimate over the past 3 months the average frequency and quantity of drinking beer, wine, or liquor. Servings per week were estimated on the basis of 12 oz of beer equivalent to 6 oz of wine and 1.5 oz of liquor for each participant.
Outcomes
Incident hospitalized HF was ascertained yearly in WHI by medical record abstraction of self-report hospitalizations and classified by trained adjudicators using the standardized methodology as previously described. 18 Hospitalized HF requiring and/or occurring during hospitalization required physician diagnosis of new-onset or worsened congestive HF on the reported hospital admission and 1 or more of the following 4 criteria: HF diagnosed by physician and receiving medical treatment for HF; symptoms plus documentation in the current medical record of a history of an imaging procedure showing impaired left ventricular (LV) systolic or diastolic LV function; pulmonary edema/congestion on chest x-ray on the current admission; dilated ventricle(s), or "poor" LV or right ventricular function by echocardiography, radionuclide ventriculography, or other contrast ventriculography or evidence of LV diastolic dysfunction. This method was found to have an excellent 79% agreement rate () comparing central adjudicated HF and local adjudication. 18 Interim CHD was defined by adjudicated hospitalization for myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass graft, or angina after baseline and before the HF hospitalization. 18 
Statistical Methods
The frequency distribution of the variables of interest was inspected to rule out anomalies and outliers resulting from measurement artifacts. Correlations among covariates were examined to evaluate collinearity. Differences in covariates by race/ethnicity and by developing incident HF were assessed to look for potential confounding relationship through the use of ANOVA and 2 testing for continuous and categorical variables.
Women with self-reported HF at baseline (nϭ2048) were excluded from the cohort, as were those with missing, other, or Native American race (nϭ2926) and those with missing covariate data (nϭ691). Age-specific and age-adjusted rates using 2000 Census data for direct adjustment by race/ethnicity were calculated. Proportional hazards models were developed for incident hospitalized HF, with adjustment for potential confounders based on the clinical literature and inclusion of other potential confounders found in the univariate analysis that differed by race and by incident HF at PϽ0. 10 . Because the entry criteria and time of observation were different between the observational study and clinical trial cohorts, we performed stratified analysis by cohort assignment and pooled the estimate of effect for each risk factor using the STRATA statement in proc PHREG in SAS.9.2. A C statistic or area under the receiver-operating characteristic curve, which compares the sensitivity and the 1Ϫspecificity, is presented to demonstrate how well the HF models discriminate cases of HF from noncases.
Population-attributable risk (PAR) percentages were calculated to evaluate the potential impact of risk factor reduction from the public health perspective using the following formula:
, where p is the proportion of the population with the risk factor and r is the relative risk estimate (hazard ratio) for the risk factor.
Results
The baseline cohort that included 156 143 postmenopausal women free of self-reported HF with complete data on confounders was analyzed; 84.3% were white, 9% were black, 4% were Hispanic, and 2.7% were Asian/Pacific Islanders. Table 1 shows the characteristics of the cohort by race/ethnicity. Significant differences between racial/ethnic groups were noted for sociodemographic factors such as age, education, and income; access-to-care and medication issues such as insurance status, hysterectomy, and hormone treatment; traditional risk factors for HF, including obesity, history of CHD, and diabetes mellitus; and lifestyle factors such as alcohol servings per week and vitamin D intake.
Incident hospitalized HF developed in an average of 7.8 years of follow-up in 3018 whites, 391 blacks, 82 Hispanics, and 37 Asian/Pacific Islanders. Age-specific and age-adjusted rates demonstrated differences by race, with blacks having the highest age-adjusted rate of incident hospitalized HF ( Figure 1A and Table 2 ). This higher rate was greatest in the group of women Ͻ60 years of age. After multiple variable adjustments for other risk factors, whites and blacks had similar rates for HF, whereas Hispanics and Asian/Pacific Islanders had persistently lower rates of HF ( Figure 1B and Table 3 ). The C statistic for the full multivariate model was Cϭ0.84 (95% confidence interval, 0.83-0.85).
To better understand which risk factors might explain the racial/ethnic differences in the incidence of HF, we performed nested models (Tables 3 and 4) comparing each race/ethnicity group with white women regarding their risk of HF. As shown in Table 3 , a model adjusting for age, income, and education had a modest effect on explaining differences between black and white women, had no effect on Asian/ Pacific Islanders, and made more apparent the lower risk of HF in Hispanics. Adjusting for established risk factors for HF to the model removed the excess risk in black compared with white women and made more apparent the lower risk of HF in Asian/Pacific Islanders and Hispanics compared with whites. Adjusting for interim CHD in addition to age, socioeconomic status, and traditional risk factors had a modest effect on the inverse relationship between Hispanic and Asian/Pacific Islander race for incident HF compared with whites. This adjustment lead to a nonsignificant excess risk in black women compared with white women. Further adjustment for all potential confounders, including access to care, medications, and other medical conditions, to the model reversed the modest excess risk associated with adjusting for interim CHD in black women and had minimal effect on the point estimates of risk for the Hispanic or Asian/Pacific Islanders.
To further explore the risk attenuation of HF in black women compared with white women and the independent contribution of prevalent and interim CHD and other potential risk factors, we evaluated risk factor-specific models (Table 4) . For black women, adjusting for age made more apparent the excess risk of HF compared with white women, whereas adjusting for diabetes mellitus, household income, education level, hysterectomy, and hormone replacement therapy use lowered the excess risk of HF compared with white women. Of note, adjusting for diabetes mellitus and household income removed the excess risk of HF completely in black women, whereas hypertension, obesity, and prevalent or interim CHD had no effect. For Hispanic women, adjusting for the confounding effects of age and interim CHD for HF led to point estimates of risk closer to the null compared with baseline risk levels, whereas adjusting for diabetes mellitus, household income, and education led to point estimates of a lower risk of HF for Hispanics compared with whites, suggesting potential mechanisms for differences in rates of incident HF for Hispanics. For Asian/Pacific Islander women, adjusting for household income and interim CHD had a modest effect on point estimates of the lower risk for HF compared with white women.
Population-attributable percentages for HF attributed to diabetes mellitus and interim CHD are shown in Figure 2 . This measure of the public health impact of these risk factors, which accounts for both the prevalence of a risk factor and its relative risk, shows that diabetes mellitus has its greatest impact on Hispanic and black women and, to a lesser extent, Asian/Pacific Islander and white postmenopausal women. Interim CHD shows a greater overall impact on the modifiable risk of HF, with its greatest effect on Hispanics, followed by Asian/Pacific Islanders, whites, and then blacks.
Discussion
This analysis of a large prospective cohort of racially and ethnically diverse postmenopausal women revealed that black women, especially those Յ60 years of age, are at higher risk of incident hospitalized HF than their white counterparts, whereas Asian/Pacific Islanders and Hispanics had lower risks of incident hospitalized HF than white postmenopausal women. Adjusting for age, socioeconomic status, and known risk factors for HF removed the excess risk for black women but did not significantly attenuate the lower risk of HF found in the Asian/Pacific Islanders and Hispanics compared with whites. For black women, the higher risk of HF compared with white women was largely explained by adjustment for diabetes mellitus and lower income levels. Populationattributable risk percentages showed the greatest public health impact for interim CHD and diabetes mellitus, with differences by race/ethnicity on their relative attributable burden on incident HF.
Our age-adjusted incidence of hospitalized HF (271.1 per 100 000 person-years) is similar to that found in the Olmsted County study, 19 which had an age-adjusted incidence of 289 per 100 000 person-years in women, and the crude incidence rate of 310 per 100 000 in the Multiethnic Study of Atherosclerosis (MESA), 12 but it differs from the Cardiovascular Health Study (CHS), 20 which had a crude incidence rate of 2460 per 100 000 person-years, and Health, Aging and Body Composition (ABC), 21 which had a crude incidence rate of 1170 per 100 000 person-years. The higher rates of incident HF in Health ABC and CHS are probably due to the older age of the CHS and Health ABC cohorts, the combination of men and women in the CHS estimates, differences in racial mix, geographic variation, and differences in the diagnostic criteria used.
A limited number of studies have evaluated the incidence of hospitalized HF in different race/ethnic groups of women. Alexander et al 22 calculated the population-based ageadjusted incidence of HF in California using administrative data in 1991 and found rates of 265 per 100 000 person-years for white women, 454 per 100 000 person-years for black women, 237 per 100 000 for Hispanic women, and 206 per 100 000 person-years for Asian/Pacific Islanders, very similar to our results. Using the MESA cohort, Bahrami et al 12 calculated rates of 240 per 100 000 person-years for whites, 460 per 100 000 person-years for blacks, 350 per 100 000 person-years for Hispanics, and 100 per 100 000 person-years Figure 1 . A, Age-adjusted cumulative incidence of heart failure in the Women's Health Initiative (WHI) cohort by race. B, Multivariate-adjusted cumulative incidence of heart failure in WHI cohort by race adjusted for age, income, education, insurance status, alcohol consumption, physical activity, current medical conditions (hypertension, diabetes, high cholesterol, coronary heart disease, atrial fibrillation, history of hysterectomy), and medication use (hormone replacement therapy, multivitamins, aspirin, angiotensin receptor blockers, ␤-blockers). PI indicates Pacific Islander. SBP indicates systolic blood pressure; BMI, body mass index; CHD, coronary heart disease; ARB, angiotensin receptor blocker; and HRT, hormone replacement therapy. P values reflect the effect of adding the risk factor on predicting heart failure in the Cox proportional hazard model, not differential effect across race/ethnicity gradient.
cohort, Bibbins-Domingo et al 13 estimated early HF rates in black women Ͻ50 years of age at 55 per 100 000 personyears, which is less than the 50-to 59-year age-specific rate of 203 per 100 000 person-years found in WHI. These differences may well be explained by the difference in rates of HF in premenopausal compared with postmenopausal women. In addition, in a comparison of the incidence rates of HF, how HF was defined, including both hospitalized and outpatient diagnosis versus only hospitalized HF, differed by study. For example, in MESA, 12 of the 79 cases of incident HF, Ϸ18% were based on outpatient diagnoses, whereas CHS, 20 Health ABC, 21 and CARDIA 13 relied on hospitalized HF or death, similar to the WHI study. The exclusion of outpatient diagnoses of HF may have underestimated mild or transient cases of HF (viral associated cardiomyopathies) but, given the large number of cases in whites and blacks, probably had little effect on overall incident rates, whereas in Hispanics and Asian Pacific Islanders with much fewer incident cases, the impact of misclassification might be greater and might tend to underestimate rates. However, the misclassification bias of not including outpatient HF diagnoses by risk factor is likely random and therefore would bias toward the null, leading to underestimation of risk factor associations by race/ethnicity.
A study in the United Kingdom 8 that evaluated southeast Asian women mainly from the Indian subcontinent compared with white women found minimally higher rates of hospitalized HF southeast Asians (430 per 100 000 person-years) compared with white women (410 per 100 000 person-years), contrary to the protective effects found in our study and in the California study, which is probably related to differences in Indo-Asian compared with Asians/Pacific Islanders found in the WHI and other US cohorts. The WHI had only a small number of women from the Indian subcontinent. Contrary to our findings and those of Alexander et al, 22 Thomas et al 9 recently published data from selected hospitals suggesting that Hispanics had greater risk for HF than whites. This cross-sectional analysis combined both men and women, and similar to many previous studies 4 -8,10,11 on the ethnic differences in HF, it is limited in terms of determining true differences in rates because of its cross-sectional nature and concerns about prevalenceincidence bias, temporal bias, and incomplete adjustment for confounding bias. Also contrary to our findings, Bahrami et al 12 found higher rates of incident HF in Hispanics compared with whites in the MESA study, but this risk did not reach statistical significance, presumably related to sample size issues. Of interest is the fact that in MESA this increased risk in Hispanics was attenuated by household income and LV mass index and to a lesser extent by hypertension, suggesting potential mechanisms important to the Hispanic population. In WHI Hispanic women, adjustment for higher household incomes led to lower risk estimates of HF, whereas development of interim CHD led to higher estimates of HF compared with whites and hypertension had no confounding effect. The explanation for the differences in risk of HF in Hispanics between the different studies is unclear but may be related to different countries of origin for Hispanics (Caribbean, Central American, South American) and the degree of acculturation in the different studies. 9, 12, 22 Why Hispanic and Asian women have lower rates of HF even after adjustment for age, socioeconomic status, and known cardiac risk factors than whites in our study remains unclear. A recent article on racial and ethnic differences in subclinical myocardial function in a population cohort free of cardiovascular disease using cardiac magnetic resonance imaging with tissue tagging found that Chinese Americans had the greatest magnitude of peak systolic strain and strain rates, consistent with the highest rate of systolic contraction, Figure 2 . Population-attributable risk percentage of diabetes mellitus and interim coronary heart disease (CHD) for incident heart failure by race/ethnic group in postmenopausal women. PI indicates Pacific Islander. *Relative risk estimates adjusted for age, income, and education.
whereas blacks had the lowest rates of peak systolic strain in the majority of wall regions and Hispanics had the lowest rate of contractility in all wall regions. 23 These regional differences in LV systolic function may provide a clue to the differential rates of HF by race and ethnicity. 23 Risk factors for hospitalized HF found in this analysis are similar to those found in other prospective studies, including older age, lower educational attainment, lower income, diabetes mellitus, and CHD. 2, 4, 12, 19 Hysterectomy was found to be a risk factor in this study, which had previously been reported as a risk factor for HF in the observational cohort of WHI. 24 Although we found hormone therapy and multivitamin use (borderline significance) to be protective, we believe these results may be confounded by past versus present use and markers for overall good health. We did not find hypertension to be a risk factor for HF in our analysis, whereas it has been found to be a risk factor in most other studies of HF. 2, 4, 12, 19, 25 We explored this anomaly using differing definitions of hypertension in the WHI data set and found that uncontrolled systolic blood pressure (systolic blood pressure Ͼ150 mm Hg and on antihypertensive medication) had a modest effect in predicting HF (Table 4 ) but no differential effect by race; therefore, we chose to use the more standard definition of hypertension for our nested model (Table 3 ) to be comparable to other studies.
The strengths of this study are that it is prospective, has an adequate sample size to evaluate racial and ethnic differences with reasonable power, and has Ͼ7.8 years of follow-up. Its limitations include the fact that although HF was a physicianadjudicated outcome using consistent clinical criteria, it was not a primary outcome of the WHI study, and thus its definition relied on clinical criteria that did not capture uniform quantitative assessment of systolic function or diastolic LV function, valvular pathology, or separate categorization for right HF. In addition, brain natriuretic peptide and other biomarkers of HF were not routinely assessed. Still, this measurement error would be nondifferential across race/ ethnicity groups and thus would bias our results toward the null. Although dietary factors were measured in this cohort, they are not reported here because they are the focus of another report. Serum creatinine and cystatin C are currently not available to assess the role of chronic kidney disease in the origin of HF in WHI. Hemoglobin levels to evaluate anemia and white blood cell count as measures of inflammation were available for analysis but did not show an association with HF in the univariate analysis; therefore, they were not evaluated as confounding risk factors.
We did not evaluate Native Americans (0.44%) in the WHI primarily because of the small numbers and therefore unstable estimates of any potential findings. Missing data were limited to Ͻ1% of the sample and thus would have negligible effects on our findings.
Conclusions
Race and ethnicity appear to play an important role in the epidemiology of incident HF, with much lower rates found in Asian/Pacific Islanders and Hispanic postmenopausal women compared with white women. Confirming the results of previous studies, we found here that black women have the highest rates of HF, especially those Ͻ60 years of age. However, these differences are completely explained by the effects of income and diabetes mellitus and not by hypertension or CHD in this cohort. Different risk factors have different effects on the incidence of HF for each racial/ethnic group, providing some insight into potential different mechanisms explaining the differential rates of incident HF. Interim CHD and diabetes mellitus have the greatest modifiable public health impact on the incidence of HF and are variable in their attribution to the incidence of HF by race/ethnicity. The mechanism of the differential attribution of risk factors by race/ethnicity needs to be explored more deeply in future cohort studies with appropriate genomic and environmental exposure data.
